It has been shown to function as a neuromodulator through the activation of purinergic receptors in astrocytes and displays protective properties by preventing the aggregation of amyloidogenic proteins—a key pathological event in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [2]. The gene discussed is P2RY1; the disease is Alzheimer disease.